Literature DB >> 11832788

Noncontraceptive health benefits of intrauterine devices: a systematic review.

David Hubacher1, David A Grimes.   

Abstract

Most women and their clinicians are unaware that IUDs confer important noncontraceptive health benefits. This review summarizes the evidence from published articles on this topic. We conducted a series of systematic literature searches to identify articles on the noncontraceptive health benefits of IUD use. We reviewed the potentially pertinent ones for content, grouped them according to type of IUD, and evaluated them using the U.S. Preventive Services Task Force rating system. Over 500 titles were identified and several hundred abstracts were reviewed. Use of nonhormonal IUDs (plastic and copper) was associated with a decrease in endometrial cancer. The levonorgestrel intrauterine system can treat a variety of gynecological disorders, including menorrhagia and anemia. The levonorgestrel system has also been used successfully as part of hormone replacement therapy, as adjuvant therapy with tamoxifen, and as an alternative to hysterectomy for women with bleeding problems. Like oral contraceptives, intrauterine contraceptives confer important noncontraceptive health benefits.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11832788     DOI: 10.1097/00006254-200202000-00024

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  15 in total

1.  Pain and heavy bleeding with intrauterine contraceptive devices.

Authors:  Sally B Rose
Journal:  BMJ       Date:  2007-09-01

2.  Evidence-based selection of candidates for the levonorgestrel intrauterine device (IUD).

Authors:  Lisa S Callegari; Blair G Darney; Emily M Godfrey; Olivia Sementi; Rebecca Dunsmoor-Su; Sarah W Prager
Journal:  J Am Board Fam Med       Date:  2014 Jan-Feb       Impact factor: 2.657

3.  Bridging the gaps among research, policy and practice in ten low- and middle-income countries: development and testing of a questionnaire for researchers.

Authors:  David Cameron; John N Lavis; G Emmanuel Guindon; Tasleem Akhtar; Francisco Becerra Posada; Godwin D Ndossi; Boungnong Boupha
Journal:  Health Res Policy Syst       Date:  2010-01-29

4.  Bridging the gaps between research, policy and practice in low- and middle-income countries: a survey of health care providers.

Authors:  G Emmanuel Guindon; John N Lavis; Francisco Becerra-Posada; Hossein Malek-Afzali; Guang Shi; C Ashok K Yesudian; Steven J Hoffman
Journal:  CMAJ       Date:  2010-05-03       Impact factor: 8.262

Review 5.  The epidemiology of endometrial and ovarian cancer.

Authors:  Daniel W Cramer
Journal:  Hematol Oncol Clin North Am       Date:  2011-11-25       Impact factor: 3.722

Review 6.  Molecular pathogenesis of endometrial and ovarian cancer.

Authors:  Melissa A Merritt; Daniel W Cramer
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

Review 7.  Efficacy and safety of long-acting reversible contraception.

Authors:  Amy Stoddard; Colleen McNicholas; Jeffrey F Peipert
Journal:  Drugs       Date:  2011-05-28       Impact factor: 9.546

Review 8.  Long-acting reversible contraception for adolescents.

Authors:  Colleen McNicholas; Jeffrey F Peipert
Journal:  Curr Opin Obstet Gynecol       Date:  2012-10       Impact factor: 1.927

9.  Contraceptive use by obese women 1 year postpartum.

Authors:  Jeanette R Chin; Geeta K Swamy; Truls Østbye; Lori A Bastian
Journal:  Contraception       Date:  2009-05-09       Impact factor: 3.375

Review 10.  Therapeutic amenorrhea in patients at risk for thrombocytopenia.

Authors:  Meredith K Martin-Johnston; Olanma Y Okoji; Alicia Armstrong
Journal:  Obstet Gynecol Surv       Date:  2008-06       Impact factor: 2.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.